Posted on 12/3/17
Corindus Partners with Houston Methodist DeBakey Heart & Vascular Center
WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Houston Methodist DeBakey Heart & Vascular Center, . . .
Posted on 12/3/17
Mauna Kea Technologies Renews Its Equity Financing Facility
PARIS & BOSTON--(BUSINESS WIRE)--Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announces the implementation of a new . . .
Posted on 12/3/17
Akebia Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 12/1/17
Ryan Burke of Peak Physical Therapy & Sports Performance Performs Dry Needling Demo at Marathon Sports in Norwell
Ryan Burke, DPT with Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and . . .
Posted on 12/1/17
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines . . .
Posted on 12/1/17
Myomo Prices Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that it has priced an underwritten public offering of 4,175,000 shares . . .
Posted on 11/30/17
scPharmaceuticals Closes Over-Allotment Option in its Initial Public Offering
BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc.(Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform the . . .
Posted on 11/30/17
scPharmaceuticals Closes IPO
BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. a pharmaceutical company focused on developing and commercializing products that have the potential to transform the . . .
Posted on 11/30/17
Regeneron and Decibel Therapeutics Announce Strategic Collaboration
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc., today announced a collaboration to discover and develop new potential therapeutics to protect, repair, and restore hearing.Decibel . . .
Posted on 12/11/17
Vedanta Biosciences Expands Network of Clinical Collaborations
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, an affiliate of PureTech Health (LSE: PRTC) developing a new category of therapies for immune-mediated and infectious diseases based on rationally designed . . .
Posted on 11/29/17
Biogen Inc. Buys Its Way Out of Competition
Biogen (NASDAQ:BIIB) is following the old saying, "If you can't beat 'em, join 'em" for its multibillion drug Tecfidera or, more accurately, "If you might not . . .
Posted on 11/28/17
Xtelligent Media Expands its Value-Based Care Events
After 3 successful events, the Value-Based Care Summit Series has expanded to share solutions to challenging population health management and telehealth business problems.Featuring real-world case studies, . . .
Posted on 11/28/17
X-Chem and Gilead Announce Drug Discovery Collaboration
WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, announced today . . .
Posted on 3/26/18
Q BioMed Adds Boston University’s Dr. Helen Tager-Flusberg to Advisory Committee
Q BioMed Inc., a New York-City-based biotechnology acceleration company, announced that Dr. Helen Tager-Flusberg from Boston University has joined its advisory committee for QBM-001, which is . . .
Posted on 11/27/17
Ampersand-backed Brammer Bio Launches Gene Therapy Product Manufacturing Operations in Massachusetts
Brammer Bio, a best-in-class cell and gene therapy contract development and manufacturing organization (CDMO)
Posted on 11/27/17
Hologic Signs Development and Distribution Agreement with Clarius Mobile Health for Innovative Ultrasound System
Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed a development and distribution agreement with Clarius Mobile Health for its wireless, handheld ultrasound scanner. The . . .
Posted on 11/25/17
Check-Cap Ltd. Closes $2.5 Million Registered Direct Offering
Check-Cap Ltd. (NASDAQ: CHEK; CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced the . . .
Posted on 11/20/17
Better Buy: Biogen Inc. vs. Gilead Sciences
Historically, Biogen (NASDAQ:BIIB) has definitely been a better stock than Gilead Sciences(NASDAQ:GILD). Whether you look at the last three, five, 10, 25 years, or even so . . .
Posted on 11/20/17
Here's What Warren Buffett Really Thinks About Bitcoin
Bitcoin is not only the top digital currency on the market today; it's an incredibly volatile investment. Opinions are sharply divided on bitcoin's suitability as a . . .
Posted on 11/20/17
The Boston Globe Names C4 Therapeutics a Top Place to Work for 2017
CAMBRIDGE, Mass.--(BUSINESS WIRE)--C4 Therapeutics (C4T) has been named one of the Top Places to Work in Massachusetts in the 10th annual employee-based survey project from The . . .
Posted on 11/20/17
Sage Therapeutics Closes $345 Million Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (Nasdaq: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the closing of . . .
Posted on 11/20/17
The Boston Globe Names Takeda Pharmaceuticals U.S.A., a Top Place to Work for 2017
Takeda Pharmaceuticals U.S.A., Inc. has been named by The Boston Globe as one of its 2017 Top Places to Work. Each year, the outlet partners with . . .
Posted on 11/17/17
scPharmaceuticals Inc. Announces Pricing of Initial Public Offering
BURLINGTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. a pharmaceutical company focused on developing and commercializing products that have the potential to transform the . . .
Posted on 11/17/17
Cue Biopharma Announces Strategic Research Collaboration and License Agreement with Merck
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cue Biopharma™, Inc., an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat cancer . . .
Posted on 11/17/17
Alnylam Pharmaceuticals Closes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the closing of its previously announced underwritten registered public offering of 6,440,000 . . .
Boston
